glp-1 induced gastroparesis Gastrointestinal effects of receptor agonists: mechanisms, management, and future directions GLP-1 receptor agonists and delayed

Of the currently available classes of glucose-lowering therapies, the glucagonlike peptide-1 (GLP-1) receptor agonist class of medications has gained popularity in recent years

NAD+ effects are reported over weeks to months of consistent supplementation

The oversimplification of GLP-1s on social media has transformed medicine into a fad, leaving users unprepared for the side effects and enchanted by the allure of advertising

To explore the relationship between cortisol and GV parameters, we employed CGM in our study to monitor blood glucose fluctuations

To view or add a comment, sign in A recent finding from Duke University School of Medicine is changing our understanding of blood sugar control

Louis Health Care System reviewed the health records of two million veterans who were treated for diabetes from October 2017 through December 2023 to determine the GLP-1 medications effects on the bodys organ systems